GT BIOPHARMA INC (GTBP)

US36254L3087 - Common Stock

3.78  +0.13 (+3.56%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to GTBP. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 153. This target is 3947.62% above the current price.
GTBP was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about GTBP.
In the previous month the buy percentage consensus was at a similar level.
GTBP was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

Price Target & Forecast

Price Low Median Mean High 3.78151.50153.00153.00157.50 - 3,907.94% 3,947.62% 3,947.62% 4,066.67%

Related screens

Up and Down Grades
Date Firm Action Rating
2023-08-08 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-07 EF Hutton Reiterate Hold -> Hold
2023-06-05 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-17 HC Wainwright & Co. Reiterate Buy -> Buy
2023-05-16 EF Hutton Reiterate Hold -> Hold
2023-04-03 HC Wainwright & Co. Reiterate Buy
2023-03-31 EF Hutton Reiterate Hold
2023-01-05 EF Hutton Initiate Hold
2022-09-13 HC Wainwright & Co. Maintains Buy
2021-05-24 HC Wainwright & Co. Initiate Buy
2021-04-13 B. Riley FBR Initiate Buy
2021-03-17 Roth Capital Initiate Buy